1. Home
  2. NRSN vs VHC Comparison

NRSN vs VHC Comparison

Compare NRSN & VHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • VHC
  • Stock Information
  • Founded
  • NRSN 2017
  • VHC 2005
  • Country
  • NRSN Israel
  • VHC United States
  • Employees
  • NRSN N/A
  • VHC N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • VHC Multi-Sector Companies
  • Sector
  • NRSN Health Care
  • VHC Miscellaneous
  • Exchange
  • NRSN Nasdaq
  • VHC Nasdaq
  • Market Cap
  • NRSN 50.1M
  • VHC 54.3M
  • IPO Year
  • NRSN 2021
  • VHC 1999
  • Fundamental
  • Price
  • NRSN $1.06
  • VHC $13.69
  • Analyst Decision
  • NRSN Buy
  • VHC
  • Analyst Count
  • NRSN 2
  • VHC 0
  • Target Price
  • NRSN $14.00
  • VHC N/A
  • AVG Volume (30 Days)
  • NRSN 353.2K
  • VHC 8.8K
  • Earning Date
  • NRSN 09-29-2025
  • VHC 08-12-2025
  • Dividend Yield
  • NRSN N/A
  • VHC N/A
  • EPS Growth
  • NRSN N/A
  • VHC N/A
  • EPS
  • NRSN N/A
  • VHC N/A
  • Revenue
  • NRSN N/A
  • VHC $50,000.00
  • Revenue This Year
  • NRSN N/A
  • VHC N/A
  • Revenue Next Year
  • NRSN N/A
  • VHC N/A
  • P/E Ratio
  • NRSN N/A
  • VHC N/A
  • Revenue Growth
  • NRSN N/A
  • VHC 733.33
  • 52 Week Low
  • NRSN $0.68
  • VHC $3.68
  • 52 Week High
  • NRSN $2.60
  • VHC $21.53
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 33.59
  • VHC 46.92
  • Support Level
  • NRSN $1.05
  • VHC $12.55
  • Resistance Level
  • NRSN $1.17
  • VHC $14.49
  • Average True Range (ATR)
  • NRSN 0.12
  • VHC 0.74
  • MACD
  • NRSN 0.01
  • VHC -0.10
  • Stochastic Oscillator
  • NRSN 10.00
  • VHC 38.51

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About VHC VirnetX Holding Corp

VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.

Share on Social Networks: